Biotech | April 22, 2022
Thermo Fisher Scientific’s Clinical Research Business named `Best CRO’ at Vaccine Excellence awards
The business is a recognized leader in managing Covid-19 and mRNA research programs
The business is a recognized leader in managing Covid-19 and mRNA research programs
With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current methods
Immune response confirmed in stand-alone influenza vaccine and combination vaccine with a potential path forward for both
Ivabradine Tablets, 5 mg and 7.5 mg have an estimated market size of US $ 102 million for twelve months ending December 2021 according to IQVIA
U GRO Capital is a listed MSME lending fintech platform
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
India-Sweden Healthcare Innovation Centre in collaboration with AIIMS Jodhpur and AstraZeneca India launches an e-learning Upskilling Program in Diabetes Management for nurses
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
Subscribe To Our Newsletter & Stay Updated
